Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Burkitt Lymphoma 1

Interventions

Rituximab 67Cyclophosphamide 39Vincristine 33Prednisone 31Doxorubicin 25Lenalidomide 18Radiotherapy 16Bendamustine Hydrochloride 14Peripheral Blood Stem Cell Transplantation 10Filgrastim 10Etoposide 10Prednisolone 8tofacitinib 7obinutuzumab 6ibritumomab tiuxetan 6fludarabine 6VAP-cyclo protocol 6Mitoxantrone 6Methylprednisolone 6Deoxycholic Acid 6Cytarabine 6Melphalan 5Dexamethasone 5Carmustine 5ibrutinib 4fludarabine phosphate 4R-CHOP protocol 4Methotrexate 4Interferon-alpha 4Idarubicin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Follicular × EPOCH protocol × Clear all
NCT00053768 2021-05-18

Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

Universität des Saarlandes

Phase 3 Completed
392 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡